In recent years, several studies have reported a relatively high frequency of polyneuropathy in patients with Parkinson’s disease (PD), in particular, in patients receiving levodopa-carbidopa intestinal gel (LCIG) infusion. In spite of the several patients investigated with nerve conduction studies, no study has prospectively explored a possible central nervous system involvement of patients receiving LCIG infusion. We prospectively evaluated eight PD patients receiving LCIG infusion, who underwent neurophysiological evaluations with nerve conduction studies, visual, somatosensory and motor evoked potentials before LCIG infusion, and 1 and 6 months after. At 6 months follow-up, we found significant reduction in sural nerve SNAP amplitude, increase of central sensory conduction time N22-P40, and increases of central motor conduction time recorded from I dorsal interosseous and tibialis anterior. In PD patients with LCIG infusion, we found a subclinical neurophysiological impairment of both peripheral and central nervous system.

Bove, F., Luigetti, M., Gallicchio, L., Recchia, V., Petruzzellis, A., Di Iorio, R., Tamma, F., Fasano, A., Central conduction abnormalities in patients receiving levodopa-carbidopa intestinal gel infusion, <<NEUROLOGICAL SCIENCES>>, 2017; 38 (10): 1869-1872. [doi:10.1007/s10072-017-3029-z] [http://hdl.handle.net/10807/130840]

Central conduction abnormalities in patients receiving levodopa-carbidopa intestinal gel infusion

Bove, Francesco;Luigetti, Marco;Di Iorio, Riccardo;Fasano, Alfonso
2017

Abstract

In recent years, several studies have reported a relatively high frequency of polyneuropathy in patients with Parkinson’s disease (PD), in particular, in patients receiving levodopa-carbidopa intestinal gel (LCIG) infusion. In spite of the several patients investigated with nerve conduction studies, no study has prospectively explored a possible central nervous system involvement of patients receiving LCIG infusion. We prospectively evaluated eight PD patients receiving LCIG infusion, who underwent neurophysiological evaluations with nerve conduction studies, visual, somatosensory and motor evoked potentials before LCIG infusion, and 1 and 6 months after. At 6 months follow-up, we found significant reduction in sural nerve SNAP amplitude, increase of central sensory conduction time N22-P40, and increases of central motor conduction time recorded from I dorsal interosseous and tibialis anterior. In PD patients with LCIG infusion, we found a subclinical neurophysiological impairment of both peripheral and central nervous system.
Inglese
Bove, F., Luigetti, M., Gallicchio, L., Recchia, V., Petruzzellis, A., Di Iorio, R., Tamma, F., Fasano, A., Central conduction abnormalities in patients receiving levodopa-carbidopa intestinal gel infusion, <<NEUROLOGICAL SCIENCES>>, 2017; 38 (10): 1869-1872. [doi:10.1007/s10072-017-3029-z] [http://hdl.handle.net/10807/130840]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/10807/130840
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 2
social impact